Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|January 1, 2009
Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cellsRoberto Papait, Lorenzo Magrassi, Dorotea Rigamonti, et al.Current Pharmaceutical Design|September 16, 2009
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical targetDorotea Rigamonti, Cesare Mutti, Chiara Zuccato, et al.Pharmacological Research|May 27, 2005
From target identification to drug screening assays for neurodegenerative diseasesChiara Zuccato, Marzia Tartari, Donato Goffredo, et al.Pharmacological Research|June 22, 2005
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's DiseaseDonato Goffredo, Dorotea Rigamonti, Chiara Zuccato, et al.BMC Neuroscience|January 21, 2010
Adaptation of NS cells growth and differentiation to high-throughput screening-compatible platesAlessia Garavaglia, Alessia Moiana, Stefano Camnasio, et al.Journal of Medicinal Chemistry|April 3, 2023
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022)Mattia Riondato, Dorotea Rigamonti, Petra Martini, et al.Pharmacological Research|June 22, 2005
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF deliveryChiara Zuccato, Daniel Liber, Catarina Ramos, et al.Bioorganic & Medicinal Chemistry|April 15, 2008
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's diseaseSamantha Leone, Cesare Mutti, Aleksey Kazantsev, et al.The Journal of Biological Chemistry|August 30, 2002
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neuronsDonato Goffredo, Dorotea Rigamonti, Marzia Tartari, et al.Biochimica Et Biophysica Acta|August 22, 2006
Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell deathXin Wang, Malini Narayanan, Jean-Marie Bruey, et al.Pageof 2